Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Gynecol Oncol. 2023 Aug 25;177:38–45. doi: 10.1016/j.ygyno.2023.08.005

Figure 1.

Figure 1.

Kaplan-Meier curves depicting (A) progression-free survival and (B) overall survival of patients with clear cell carcinoma subtypes. CC, pure clear cell carcinoma; CC-EM-M, mixed clear cell and endometrioid carcinoma; CC-SER-M, mixed clear cell and serous carcinoma; CC-EM-I, indeterminate clear cell vs. endometrioid carcinoma; CC-SER-I, indeterminate clear cell vs. serous carcinoma. In both panels, survival of patients with grade 3 pure endometrioid carcinoma (EM) and pure serous carcinoma (SER) are plotted for comparison.